AtriCure (ATRC) Receivables (2010 - 2026)

AtriCure (ATRC) has 17 years of Receivables data on file, last reported at $71.3 million in Q1 2026.

• On a quarterly basis, Receivables rose 12.62% year-over-year to $71.3 million in Q1 2026; TTM through Mar 2026 was $71.3 million, a 12.62% increase from a year earlier, with the FY2025 full-year figure at $66.7 million, up 10.46% from the prior year.
• Receivables for Q1 2026 stood at $71.3 million, up from $66.7 million in the prior quarter.
• Over the last five years, Receivables for ATRC reached as high as $71.3 million in Q1 2026 and fell as low as $40.9 million in Q1 2022.
• Historically, Receivables has averaged $54.2 million across 5 years, with a median of $54.9 million in 2024.
• Across the five-year window, Receivables surged 37.45% in 2022 and gained 6.56% in 2024, its largest moves.
• Year by year, Receivables stood at $42.7 million in 2022, then increased by 22.97% to $52.5 million in 2023, then climbed by 14.93% to $60.3 million in 2024, then increased by 10.46% to $66.7 million in 2025, then gained by 6.99% to $71.3 million in 2026.
• Per Business Quant data, the three most recent Receivables figures were $71.3 million in Q1 2026, $66.7 million in Q4 2025, and $63.0 million in Q3 2025.